63% of Pharmaceutical Experts Expect Outsourcing Activity to Increase
With increasing pressure on pharmaceutical organisations to cut costs and streamline processes, many are deciding to outsource clinical trials. In the current economic climate, outsourcers can provide a key way to continue drug development and trials without incurring the associated costs. Most successful drugs carry the burden of attrition – those that have failed in late stages or in clinical trials. For some, outsourcing clinical trials is the answer.
Have Your Say
Rate this feature and give us your feedback in the comments section below
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.